The U.S. Department of Health and Human Services (HHS) recently announced an expansion of its use of artificial intelligence to identify potential fraud, waste, and compliance issues involving federal healthcare funding. The initiative is intended to enhance oversight of public healthcare programs and improve the government’s ability to detect unresolved audit findings and other areas of concern.
New AI-Driven Review Initiative
The program, known as Audit Enforcement and Risk Oversight (AERO), will utilize advanced artificial intelligence tools to review audit reports from recipients of federal healthcare funding across all 50 states.
According to HHS, the initiative will analyze at least five years of audit history in an effort to identify unresolved deficiencies, recurring compliance issues, and other indicators of potential risk. The agency has stated that AI technology will allow it to review large volumes of audit material more efficiently than traditional manual processes.
Gustav Chiarello, Assistant Secretary for Financial Resources and leader of the initiative, indicated that HHS plans to use ChatGPT and other AI-based technologies to assist with the review process. He noted that these tools can evaluate lengthy audit reports that might otherwise receive limited scrutiny due to resource constraints.
Increased Focus on Accountability
As part of the rollout, HHS sent notices to all 50 states informing them of the new initiative and emphasizing the agency’s increased focus on audit compliance and corrective action.
While the agency has warned that unresolved deficiencies could potentially result in the loss of federal funding, it has not announced specific timelines for corrective action or indicated when any funding restrictions might be imposed.
HHS has also not disclosed the full range of AI technologies being utilized, nor has it specified whether those tools were developed internally or supplied by third-party vendors.
Early Findings
Although formal results have not yet been released, HHS has reported preliminary concerns arising from the initiative. According to the agency, early reviews suggest that numerous audit findings have remained unresolved and that hundreds of federal funding recipients may have failed to submit required audit reports.
These observations have reinforced the agency’s view that stronger oversight and enforcement measures are needed.
Part of a Broader Anti-Fraud Strategy
The AERO initiative is one component of a larger effort by HHS to combat fraud, waste, and abuse within federally funded healthcare programs.
Recent actions have included:
- Increased scrutiny of Medicaid funding and compliance
- Medicare enrollment freezes in certain circumstances
- Expanded audit requirements for Medicaid providers
- Enhanced monitoring of federal healthcare grants and funding recipients
Taken together, these measures reflect the agency’s growing emphasis on financial accountability and program integrity.
What Healthcare Organizations Should Consider
Hospitals, healthcare providers, state agencies, and other recipients of federal healthcare funding should expect heightened attention to audit findings and compliance obligations.
Organizations may wish to:
- Review prior audit findings and corrective action plans
- Ensure required audits are completed and submitted on time
- Evaluate internal compliance and reporting procedures
- Monitor future guidance and enforcement activity from HHS
As the agency continues to expand its use of AI-driven oversight tools, healthcare organizations that receive federal funding may face increased scrutiny regarding both historical and ongoing compliance efforts.
Looking Ahead
The use of artificial intelligence in healthcare oversight represents a significant shift in how federal agencies approach fraud detection and compliance monitoring. By leveraging AI to analyze large volumes of audit data, HHS aims to identify risks more efficiently and hold funding recipients accountable for unresolved deficiencies.
As additional details and enforcement outcomes emerge, healthcare organizations should continue monitoring developments closely and ensure that compliance programs are positioned to address evolving regulatory expectations.